Fifth AACR International Meeting
In cooperation with the International Conference on Malignant Lymphoma (ICML)

June 24-27, 2026
Hilton Philadelphia at Penn’s Landing
Philadelphia, Pennsylvania

Conference chair

Michael R. Green, The University of Texas MD Anderson Cancer Center, Houston, Texas

Conference cochairs

Francesco Bertoni*, Institute of Oncology Research, Bellinzona, Switzerland
Christopher R. Flowers, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jean L. Koff, Winship Cancer Institute of Emory University, Atlanta, Georgia
Ari M. Melnick, Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Laura Pasqualucci, Columbia University Irving Comprehensive Cancer Center, New York, New York
Margaret A. Shipp, Dana Farber Cancer Institute, Boston, Massachusetts

*ICML Representative

The fifth Advances in Malignant Lymphoma: From Discovery to Clinical Impact conference, held in cooperation with the International Conference on Malignant Lymphoma (ICML), will convene experts from academia, industry, government, and foundations to examine how molecular mechanisms and translational research are driving therapeutic progress. The program will highlight advances in understanding germinal center biology and beyond, lymphoma origins and classifications, including rare and aggressive subtypes, and microenvironmental influences, that define disease behavior and therapeutic response.

This conference is uniquely positioned to integrate scientific discoveries across epigenetics, disease modeling, and computational biology with emerging therapeutic advances in antibody evolution, next-generation clinical assessment, degraders, and cellular therapies. Together, these efforts will capture the entire spectrum of lymphoma research and drive progress toward improved patient outcomes.

Please Note: All presentations at this event represent the opinions of the presenter and do not represent the position or the opinion of the AACR or its members.